Aktis Oncology, Inc.(AKTS)
$16.40+0.30 (+1.86%)
AKTS
Aktis Oncology, Inc. financials statements
$16.40
At close:+0.30 (+1.86%)
Want to see AKTS full AI Analyst Report?
Aktis Oncology, Inc. (AKTS) Ratios
43 Followers
Aktis Oncology, Inc. Ratios
AKTS's free cash flow for Q3 2026 was $-26.82M. For the 2026 fiscal year, AKTS's free cash flow was decreased by $-772.00K and operating cash flow was $-26.05M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 7.37 | 15.98 | 16.07 | 25.11 |
| Quick Ratio | 7.37 | 15.98 | 16.07 | 25.11 |
| Cash Ratio | 1.21 | 1.97 | 4.73 | 24.38 |
| Solvency Ratio | -0.15 | -0.10 | -0.16 | -0.11 |
| Operating Cash Flow Ratio | -2.05 | 0.78 | -4.81 | -3.44 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -180.72M | $ -113.13M | $ -68.46M | $ -25.07M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.04 | 0.04 | 0.11 | 0.01 |
| Debt-to-Equity Ratio | -0.08 | -0.14 | -0.29 | -0.09 |
| Debt-to-Capital Ratio | -0.09 | -0.16 | -0.41 | -0.10 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -1.81 | -3.71 | -2.64 | -7.19 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.22 | 0.34 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.43 | 0.59 | 0.48 | 6.56 |
| Profitability Margins | ||||
| Gross Profit Margin | 100.00% | 100.00% | 0.00% | 0.00% |
| EBIT Margin | -980.93% | -2957.63% | 0.00% | 0.00% |
| EBITDA Margin | -945.08% | -2851.71% | 0.00% | 0.00% |
| Operating Profit Margin | -1149.52% | -3500.34% | 0.00% | 0.00% |
| Pretax Profit Margin | -980.93% | -2957.63% | 0.00% | 0.00% |
| Net Profit Margin | -980.93% | -2957.63% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -980.93% | -2957.63% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 85.33% | 84.50% | 82.32% | 90.72% |
| Return on Assets (ROA) | -24.06% | -13.48% | -23.41% | -12.96% |
| Return on Equity (ROE) | 43.61% | 50.09% | 61.85% | 93.23% |
| Return on Capital Employed (ROCE) | -31.96% | -16.93% | -29.96% | -14.85% |
| Return on Invested Capital (ROIC) | -31.79% | -16.86% | -29.58% | -14.76% |
| Return on Tangible Assets | -24.06% | -13.48% | -23.41% | -12.96% |
| Earnings Yield | -5.42% | -5.63% | 0.00% | 0.00% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.24 | 0.07 | 0.00 | 0.00 |
| Asset Turnover | 0.02 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.03 | 0.01 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -1.22 | 0.42 | 0.00 | 0.00 |
| Free Cash Flow Per Share | -1.40 | 0.34 | 0.00 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | -6.69 | 5.16 | -7.97 | -7.86 |
| Capital Expenditure Coverage Ratio | -6.69 | 5.16 | -7.97 | -7.86 |
| Operating Cash Flow Coverage Ratio | -5.55 | 1.23 | -2.24 | -10.21 |
| Operating Cash Flow to Sales Ratio | -9.87 | 9.93 | 0.00 | 0.00 |
| Free Cash Flow Yield | -6.27% | 1.52% | 0.00% | 0.00% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -18.82 | -17.78 | 0.00 | 0.00 |
| Price-to-Sales (P/S) Ratio | 181.08 | 525.20 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -8.05 | -8.89 | 0.00 | 0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -15.96 | 65.63 | 0.00 | 0.00 |
| Price-to-Operating Cash Flow Ratio | -18.35 | 52.90 | 0.00 | 0.00 |
| Price-to-Earnings Growth (PEG) Ratio | 3.39 | -0.33 | 0.00 | 0.00 |
| Enterprise Value Multiple | -18.73 | -17.82 | 0.48 | 6.56 |
| Enterprise Value | 1.15B | 755.82M | -16.11M | -126.82M |
| EV to EBITDA | -18.73 | -17.82 | 0.48 | 6.56 |
| EV to Sales | 177.05 | 508.29 | 0.00 | 0.00 |
| EV to Free Cash Flow | -15.61 | 63.51 | 0.48 | 6.21 |
| EV to Operating Cash Flow | -17.94 | 51.20 | 0.54 | 7.00 |
| Tangible Book Value Per Share | -2.78 | -2.52 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | -2.78 | -2.52 | 0.00 | 0.00 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.12 | 0.04 | 0.00 | 0.00 |
| Net Income Per Share | -1.21 | -1.26 | 0.00 | 0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.82 | 0.91 |
| Research & Development to Revenue | 10.38 | 27.54 | 0.00 | 0.00 |
| SG&A to Revenue | 1.94 | 7.60 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.79 | 1.52 | 0.00 | 0.00 |
| Income Quality | 1.01 | -0.34 | 1.05 | 1.01 |
Currency in USD

